We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current AMP market cap is 4.08B. The company's latest EPS is EUR 1.1919 and P/E is 27.02.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 1.73B | 1.57B | 1.99B | 2.13B | 2.27B |
| Operating Income | 177.28M | 168.15M | 245.67M | 279.31M | 260.27M |
| Net Income | 108.67M | 101M | 157.79M | 178.53M | 155.14M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 2.85B | 3.23B | 3.52B | 3.58B | 3.69B |
| Total Liabilities | 2.16B | 2.43B | 2.59B | 2.54B | 2.59B |
| Total Equity | 696.12M | 801.87M | 927.28M | 1.04B | 1.1B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 319.37M | 391.47M | 462.37M | 458.62M | 413.54M |
| Investing | -161.69M | -134.28M | -533.61M | -193.78M | -261.48M |
| Financing | -111.32M | 151.52M | -208.64M | -353.8M | -135.06M |
| Market Cap | 4.08B |
| Price to Earnings Ratio | 27.02 |
| Price to Sales Ratio | 1.85 |
| Price to Cash Ratio | 21.7 |
| Price to Book Ratio | 3.8 |
| Dividend Yield | 0.93% |
| Shares Outstanding | 130.16M |
| Average Volume (1 week) | 541.52k |
| Average Volume (1 Month) | 657.34k |
| 52 Week Change | -4.28% |
| 52 Week High | 36.27 |
| 52 Week Low | 24.49 |
| Spread (Intraday) | 0.45 (1.43%) |
| Company Name | Amplifon |
| Address |
via g ripamonti 131/133 milan, lombardy 20141 |
| Website | https://www.amplifon.com |
| Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
